<?xml-stylesheet type="text/xsl" href="ViewNLM-v2.3.xsl"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Korean Med Sci</journal-id><journal-id journal-id-type="publisher-id">JKMS</journal-id><journal-title-group><journal-title>Journal of Korean Medical Science</journal-title></journal-title-group><issn pub-type="ppub">1011-8934</issn><issn pub-type="epub">1598-6357</issn><publisher><publisher-name>The Korean Academy of Medical Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">15608388</article-id><article-id pub-id-type="pmc">2816295</article-id><article-id pub-id-type="doi">10.3346/jkms.2004.19.6.800</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Production of Chemokines in Kawasaki Disease, Henoch-Sch&#x000f6;nlein Purpura and Acute Febrile Illness</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chung</surname><given-names>Hyo Seok</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Hyo Young</given-names></name><xref ref-type="aff" rid="A2">*</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Hee Sun</given-names></name><xref ref-type="aff" rid="A2">*</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Hee Jung</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Yuh</surname><given-names>Ji Hyun</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Eun Sil</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Choi</surname><given-names>Kwang Hae</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Lee</surname><given-names>Young Hwan</given-names></name><xref ref-type="aff" rid="A1"/></contrib></contrib-group><aff id="A1">Department of Pediatrics, Yeungnam University, College of Medicine, Daegu, Korea.</aff><aff id="A2"><label>*</label>Department of Microbiology, Yeungnam University, College of Medicine, Daegu, Korea.</aff><author-notes><corresp>
Address for correspondence: Young Hwan Lee, M.D. Department of Pediatrics, Yeungnam University Hospital, 317-1 Daemyung-dong, Nam-gu, Daegu 703-717, Korea. Tel: +82.53-620-3535, Fax: +82.53-629-2252, <email>yhlee@med.yu.ac.kr</email></corresp></author-notes><pub-date pub-type="ppub"><month>12</month><year>2004</year></pub-date><pub-date pub-type="epub"><day>31</day><month>12</month><year>2004</year></pub-date><volume>19</volume><issue>6</issue><fpage>800</fpage><lpage>804</lpage><history><date date-type="received"><day>29</day><month>4</month><year>2004</year></date><date date-type="accepted"><day>14</day><month>7</month><year>2004</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2004 The Korean Academy of Medical Sciences</copyright-statement><copyright-year>2004</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>We compared the production of three chemokines; interferon-&#x003b3;-inducible protein-10 (IP-10), monocyte chemoattractant protein-1 (MCP-1) and growth-related oncogene-&#x003b1; (Gro-&#x003b1;) that attracts monocytes or neutrophils, or both, in peripheral blood at acute stage of Kawasaki disease (n=29), Henoch-Sch&#x000f6;nlein purpura (n=15) and acute febrile illnesses (n=12). The production of the chemokines was assayed by ELISA. The plasma levels of IP-10 were markedly elevated in Kawasaki disease (538.6&#x000b1;336.4 pg/mL) and acute febrile illnesses (417.1&#x000b1;262.2 pg/mL) compared with in Henoch-Sch&#x000f6;nlein purpura (58.7&#x000b1;95.7 pg/mL) (<italic>p</italic>&#x0003c;0.05). The MCP-1 levels were elevated in Kawasaki disease (443.0&#x000b1;473.1 pg/mL) and acute febrile illnesses (328.6&#x000b1;261.1 pg/mL) compared with in Henoch-Sch&#x000f6;nlein purpura (82.9&#x000b1;79.0 pg/mL) (<italic>p</italic>&#x0003c;0.05). The Gro-&#x003b1; levels were elevated only in acute febrile illnesses (134.3&#x000b1;153.6 pg/mL) compared with in Kawasaki disease (31.8&#x000b1;22.1 pg/mL) or Henoch-Sch&#x000f6;nlein purpura (29.4&#x000b1;53.3 pg/mL) (<italic>p</italic>&#x0003c;0.05). According to these results, monocytes may play an important role in Kawasaki disease. In acute febrile illnesses, both monocytes and neutrophils may play an important role. By contrast, Henoch-Sch&#x000f6;nlein purpura may not be associated with the role of monocytes and neutrophils. Further studies using a larger number of cases are needed.</p></abstract><kwd-group><kwd>Mucocutaneous Lymph Node Syndrome</kwd><kwd>Kawasaki Disease</kwd><kwd>Purpura, Sch&#x000f6;nlein-Henoch</kwd><kwd>Acute Febrile Illness</kwd><kwd>Measles</kwd><kwd>Gastroenteritis</kwd><kwd>Pneumonia</kwd><kwd>Tonsillitis</kwd><kwd>Mumps</kwd><kwd>Exanthem Subitum</kwd><kwd>Chemokines, CC</kwd><kwd>Chemokines, CXC</kwd><kwd>Chemokines</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Kawasaki disease, first described by Dr. Tomisaku Kawasaki in Japan in 1967, is acute febrile vasculitis in childhood characterized by prolonged fever, polymorphous skin rash, non-purulent conjunctivitis, oral mucositis, erythematous induration of extremities, and cervical lymphadenopathy (<xref ref-type="bibr" rid="B1">1</xref>).</p><p>The differential diagnosis includes scarlet fever, toxic shock syndrome, measles, drug reaction, viral infection and other vasculitis syndromes. It can be difficult to differentiate from other acute febrile illnesses, because of some clinical and epidemiologic features support an infectious origin. From the histopathological aspects, Kawasaki disease is vasculitis in the small and medium-sized blood vessels (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>), similar to Henoch-Sch&#x000f6;nlein purpura, which is the most commonly encountered vasculitis syndrome in childhood. Especially, the interaction between leukocytes and vascular endothelial cells contributes to pathogenesis of these diseases (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>). So it is important to understand the factors that may recruit and activate leukocytes to the regions of vasculitis in both diseases.</p><p>Chemokine is one of the most important factors in this process (<xref ref-type="bibr" rid="B6">6</xref>). Recently, many studies in vestigated chemokines to understand the factors that may recruit and activate leukocytes to the regions of vasculitis in several diseases (<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B11">11</xref>).</p><p>In the present study, we compared the production of three chemokines; interferon-&#x003b3;-inducible protein-10 (IP-10), monocyte chemoattractant protein-1 (MCP-1) and growth-related oncogene-&#x003b1; (Gro-&#x003b1;) in peripheral blood from patients with Kawasaki disease, Henoch-Sch&#x000f6;nlein purpura and other acute febrile illnesses, which overlap each other in some clinical or pathological findings.</p></sec><sec sec-type="methods"><title>MATERIALS AND METHODS</title><sec><title>Study population</title><p>All patients were prospectively evaluated at the Department of Pediatrics, Yeungnam University Hospital, Daegu, Korea, between February 2001 and May 2003. The patients were composed of three groups: the first group included 29 patients (16 males and 13 females; mean age, 2.43 yr, range 6 months to 7 yr) at the acute febrile stage of Kawasaki disease. The second group included 15 patients (11 males and 4 females; mean age, 6.07 yr, range 2 to 14 yr) at the acute stage of Henoch-Sch&#x000f6;nlein purpura. The third group included 12 patients (6 males and 6 females; mean age, 3.4 yr, range 1 month to 8 yr) at the acute febrile stage of illnesses, such as measles (3 cases), acute gastroenteritis (<xref ref-type="bibr" rid="B2">2</xref>), pneumonia (<xref ref-type="bibr" rid="B2">2</xref>), pharyngotonsillitis (<xref ref-type="bibr" rid="B2">2</xref>), and one each case of mumps, exanthem subitum, and urinary tract infection (<xref ref-type="table" rid="T1">Table 1</xref>).</p></sec><sec><title>Sampling</title><p>Peripheral blood sample (5 mL) were drawn from the patients at acute stage, and were centrifuged at 2,000 rpm/min for 30 min. Plasma samples were frozen at -70&#x02103; for the ELISA assay.</p></sec><sec><title>ELISA assay</title><p>ELISAs for IP-10, MCP-1 and GRO-&#x003b1; were performed according to the manufacturer's instruction using the kits from the R&#x00026;D systems (Minneapolis, MN, U.S.A.). Briefly, standards and patient plasma were incubated in anti-human IP-10 (or MCP-1 or Gro-&#x003b1;) coated plates, 100 &#x000b5;L per well, at room temperature for 2 hr. Then the plates were further incubated with 200&#x000b5;L of prepared biotinylated antibody at room temperature for 1 hr, and then 200 &#x000b5;L of tetramethylbenzidine substrate solution was added for development in darkness at room temperature for 20 min. The reaction was stopped by adding of 50 &#x000b5;L of stop solution. The absorbance was measured at 450 nm for IP-10, MCP-1 and GRO-&#x003b1;.</p></sec><sec><title>Statistical analysis</title><p>Data were expressed as mean&#x000b1;standard deviation. The significance of differences was assessed by the Mann-Whitney test. A <italic>p</italic>-value&#x0003c;0.05 was considered significant.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title>Plasma levels of IP-10</title><p>The plasma levels of IP-10 were markedly elevated in the patients with Kawasaki disease (538.6&#x000b1;336.4 pg/mL) and those with acute febrile illnesses (417.1&#x000b1;262.2 pg/mL) compared with in the Henoch-Sch&#x000f6;nlein purpura group (58.7&#x000b1;95.7 pg/mL) (<italic>p</italic>&#x0003c;0.05) (<xref ref-type="table" rid="T1">Table 1</xref>, <xref ref-type="fig" rid="F1">Fig. 1</xref>). There was no statistical significance between Kawasaki disease and acute febrile illnesses.</p></sec><sec><title>Plasma levels of MCP-1</title><p>The MCP-1 plasma levels were elevated in the patients with Kawasaki disease (443.0&#x000b1;473.1 pg/mL) and those with acute febrile illnesses (328.6&#x000b1;261.1 pg/mL) compared with Henoch-Sch&#x000f6;nlein purpura group (82.9&#x000b1;79.0 pg/mL) (<italic>p</italic>&#x0003c;0.05) (<xref ref-type="table" rid="T2">Table 2</xref>, <xref ref-type="fig" rid="F2">Fig. 2</xref>). In addition, the plasma levels of MCP-1 were not elevated in 8 patients with Kawasaki disease, with less than 100 pg/mL.</p></sec><sec><title>Plasma levels of Gro-&#x003b1;</title><p>The Gro-&#x003b1; levels were elevated only in the patients with acute febrile illnesses (134.3&#x000b1;153.6 pg/mL) (<xref ref-type="table" rid="T2">Table 2</xref>, <xref ref-type="fig" rid="F3">Fig. 3</xref>). As in the MCP-1, the Gro-&#x003b1; level was extremely low in 2 patients with pharyngotonsillitis among the patients with acute febrile illnesses with 3.12 pg/mL and 6.10 pg/mL, respectively.</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>The chemokine (chemotactic cytokine) is a large family of cytokines composed of small pro-inflammatory peptides that regulate trafficking, activation and proliferation of myeloid, lymphoid, melanocytes, and vascular endothelial cells. The chemokines are divided into four groups; C, C-C, C-X-C and C-X<sub>3</sub>-C, based on the number of amino acids between the first two cysteines (<xref ref-type="bibr" rid="B6">6</xref>).</p><p>The selective attraction of leukocytes in response to chemokines may be determined by the expression of specific chemokine receptors on their cell surface. For example, neutrophils express receptors for C-X-C chemokines, but not for C-C chemokines. In general, C-X-C chemokines attract neutrophils, but not monocytes, while C-C chemokines do the reverse (<xref ref-type="bibr" rid="B6">6</xref>).</p><p>The chemokine IP-10 is the only member of C-X-C chemokines that attracts monocytes and T lymphocytes. The IP-10 secretion has been detected in macrophages, endothelial cells, keratinocytes and activated T cells in response to a number of activating stimuli, such as IFN-&#x003b1; and TNF&#x003b1;. IP-10 is involved in delayed type hypersensitivity and participates in the pathogenesis of infection and shock, such as acute Lassa fever (<xref ref-type="bibr" rid="B10">10</xref>), and canine endotoxemia (<xref ref-type="bibr" rid="B11">11</xref>). In addition, it has been shown to be associated with inflammatory responses of immune-mediated diseases, such as rheumatoid arthritis, graft rejection and tuberculosis. In the present study, the plasma level of IP-10 was markedly elevated in Kawasaki disease and acute febrile illnesses compared with Henoch-Sch&#x000f6;nlein purpura.</p><p>The chemokine MCP-1, a member of the C-C family of chemokines, attracts monocytes and lymphocyte, but not neutrophils (<xref ref-type="bibr" rid="B12">12</xref>-<xref ref-type="bibr" rid="B15">15</xref>). MCP-1 has been involved to elicit degranulation and respiratory burst in monocytes and cytokine production in these cells. In this regard, MCP-1 has been called as monocyte chemotactic and activating factor (MCAF). MCP-1 is also a potent histamine-releasing agent since it attracts monocytes that secrete supernatants, containing histamine release factors. In this study, MCP-1 was elevated in the patients with Kawasaki disease and acute febrile illnesses compared with in the Henoch-Sch&#x000f6;nlein purpura group. However, the plasma levels of MCP-1 were not elevated consistently. In 8 cases of Kawasaki disease, the MCP-1 levels were below 100 pg/mL. Further studies incorporating a larger number of cases are needed.</p><p>Gro-&#x003b1; is a member of C-X-C chemokines that attracts neutrophils, monocytes, basophils and lymphocytes. Gro-&#x003b1; contributes to the ongoing inflammatory process and neutrophil infiltration associated with various diseases (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B16">16</xref>-<xref ref-type="bibr" rid="B22">22</xref>). In the present study, Gro-&#x003b1; was elevated only in acute febrile illnesses compared with in Kawasaki disease and Henoch-Sch&#x000f6;nlein purpura.</p><p>The interaction between leukocytes and vascular endothelial cells contributes to the pathogenesis of Kawasaki disease. This immune activation accompanied by elevated levels of various pro-inflammatory cytokines. Increased production of tumor necrosis factor &#x003b1; (TNF-&#x003b1;), interleukin (IL)-1&#x003b2;, IL-2, interferon (IFN)-&#x003b1;, IL-6, IL-8, RANTES, MCP-1, macrophage inflammatory protein-1&#x003b2;, (MIP-1&#x003b2;) and IP-10 has been detected in peripheral blood of patients with Kawasaki disease (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B22">22</xref>-<xref ref-type="bibr" rid="B25">25</xref>).</p><p>Henoch-Sch&#x000f6;nlein purpura is one of the vasculitis disorders with rash, arthritis, abdominal pain and renal involvements (<xref ref-type="bibr" rid="B26">26</xref>). Although Henoch-Sch&#x000f6;nlein purpura has been suggested to represent an immunoglobulin A related immune complex disease, the pathogenesis has not been fully elucidated. Acute inflammation in Henoch-Sch&#x000f6;nlein purpura manifests as leukocytoclastic vasculitis on light microscopy. Although the factors that determine and mediate the severity of Henoch-Sch&#x000f6;nlein purpura remain poorly understood, proinflammatory cytokines such as IL-1, IL-6 and TNF-&#x003b1; (<xref ref-type="bibr" rid="B27">27</xref>-<xref ref-type="bibr" rid="B30">30</xref>) may be involved. Besbas et al. (<xref ref-type="bibr" rid="B28">28</xref>) demonstrated that TNF-&#x003b1; and IL-1&#x003b2; levels are high in the acute phase of Henoch-Sch&#x000f6;nlein purpura. Wu et al. (<xref ref-type="bibr" rid="B29">29</xref>) also demonstrated that TNF-&#x003b1; and IL-1&#x003b2; levels were high in Henoch-Sch&#x000f6;nlein purpura glomerulonephritis.</p><p>Many pro-inflammatory cytokines such as IL-1, IL-6, IL-8, TNF-&#x003b1; and IP-10 are involved in the pathogenesis of other febrile processes (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B31">31</xref>-<xref ref-type="bibr" rid="B34">34</xref>). Cha et al. observed the elevated levels of IL-6 on stimulation of <italic>Candida albicans</italic> (<xref ref-type="bibr" rid="B33">33</xref>). Valbuena et al. also detected elevation of MCP-1 in response to the infection of spotted fever group rickettsiae (<xref ref-type="bibr" rid="B34">34</xref>). We also observed Gro-&#x003b1; was elevated in measles, mumps and other viral infections. Interestingly, however, Gro-&#x003b1; was extremely low in 2 patients with pharyngotonsillitis among the acute febrile illnesses. Regrettably, the causative organisms in the patients with pharyngotonsillitis were not identified.</p><p>In conclusion, during the acute stage of Kawasaki disease, the IP-10 and MCP-1 levels were elevated. IP-10, MCP-1 and Gro-&#x003b1; were elevated during the other acute febrile illnesses. By contrast, none of these chemokines were elevated in Henoch-Sch&#x000f6;nlein purpura. According to these results, monocytes may play an important role in Kawasaki disease. In other acute febrile illnesses, both monocytes and neutrophils may play an important role. Henoch-Sch&#x000f6;nlein purpura may not be associated with the role of monocytes and neutrophils. Further studies are needed to define the clear relationship between the chemokines and neutrophils in these illnesses.</p></sec></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>This study was supported by the 2003 research grant from Yeungnam University.</p></ack><fn-group><fn fn-type="supported-by"><p>This study was supported by the 2003 research grant from Yeungnam University.</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawasaki</surname><given-names>T</given-names></name></person-group><article-title>Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children</article-title><source>Arerugi (Jpn J Allerg)</source><year>1967</year><volume>16</volume><fpage>178</fpage><lpage>222</lpage></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujiwara</surname><given-names>H</given-names></name><name><surname>Hamashima</surname><given-names>Y</given-names></name></person-group><article-title>Pathology of the heart in Kawasaki disease</article-title><source>Pediatrcs</source><year>1978</year><volume>61</volume><fpage>100</fpage><lpage>107</lpage></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirose</surname><given-names>S</given-names></name><name><surname>Hamashima</surname><given-names>Y</given-names></name></person-group><article-title>Morphological observations on the vasculitis in the mucocutaneous lymph node syndrome: A skin biopsy study of 27 patients</article-title><source>Eur J Pediatr</source><year>1978</year><volume>129</volume><fpage>17</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">679953</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>DY</given-names></name></person-group><article-title>Immunologic aspects of Kawasaki syndrome</article-title><source>J Rheumatol Suppl</source><year>1990</year><volume>24</volume><fpage>15</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">1700120</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>TJ</given-names></name><name><surname>Kallenberg</surname><given-names>CG</given-names></name></person-group><person-group person-group-type="editor"><name><surname>The</surname><given-names>TH</given-names></name><name><surname>De Kallenberg</surname><given-names>CGM</given-names></name><name><surname>Leij</surname><given-names>L</given-names></name></person-group><article-title>Vasculitis</article-title><source>Klinische Immunologie</source><year>1991</year><publisher-loc>Houten/Antwerpen</publisher-loc><publisher-name>Bohn Stafleu Van Loghum</publisher-name><fpage>216</fpage><lpage>233</lpage></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Schall</surname><given-names>TJ</given-names></name></person-group><article-title>The chemokines</article-title><source>The chemokine Handbook</source><year>1994</year><edition>2nd ed</edition><publisher-loc>New york</publisher-loc><publisher-name>Academic Press</publisher-name><fpage>419</fpage><lpage>460</lpage></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueno</surname><given-names>Y</given-names></name><name><surname>Takano</surname><given-names>N</given-names></name><name><surname>Kanegane</surname><given-names>H</given-names></name><name><surname>Yokoi</surname><given-names>T</given-names></name><name><surname>Yachie</surname><given-names>A</given-names></name><name><surname>Miyawaki</surname><given-names>T</given-names></name><name><surname>Taniguchi</surname><given-names>N</given-names></name></person-group><article-title>The acute phase nature of interleukin-6: studies in Kawasaki disease and other febrile illnesses</article-title><source>Clin Exp Immunol</source><year>1989</year><volume>76</volume><fpage>337</fpage><lpage>342</lpage><pub-id pub-id-type="pmid">2473858</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Kim</surname><given-names>WD</given-names></name><name><surname>Lee</surname><given-names>YH</given-names></name></person-group><article-title>Production and expression of Gro-&#x003b1; and RANTES by peripheral blood mononuclear cells isolated from patients with kawasaki disease and measles</article-title><source>J Korean Med Sci</source><year>2003</year><volume>18</volume><fpage>381</fpage><lpage>386</lpage><pub-id pub-id-type="pmid">12808325</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Richmond</surname><given-names>A</given-names></name><name><surname>Shattuck</surname><given-names>RL</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Horuk</surname><given-names>R</given-names></name></person-group><article-title>Melanoma growth stimulatory activity: physiology, biology, structure/function, and role in disease</article-title><source>Chemoattractant Ligands and their Receptors</source><year>1966</year><publisher-loc>Boca Raton</publisher-loc><publisher-name>CRC Press</publisher-name><fpage>87</fpage><lpage>124</lpage></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahanty</surname><given-names>S</given-names></name><name><surname>Bausch</surname><given-names>DG</given-names></name><name><surname>Thomas</surname><given-names>RL</given-names></name><name><surname>Goba</surname><given-names>A</given-names></name><name><surname>Bah</surname><given-names>A</given-names></name><name><surname>Peters</surname><given-names>CJ</given-names></name><name><surname>Rollin</surname><given-names>PE</given-names></name></person-group><article-title>Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever</article-title><source>J Infect Dis</source><year>2001</year><volume>183</volume><fpage>1713</fpage><lpage>1721</lpage><pub-id pub-id-type="pmid">11372023</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frangogiannis</surname><given-names>NG</given-names></name><name><surname>Mendoza</surname><given-names>LH</given-names></name><name><surname>Smith</surname><given-names>CW</given-names></name><name><surname>Michael</surname><given-names>LH</given-names></name><name><surname>Entman</surname><given-names>ML</given-names></name></person-group><article-title>Induction of the synthesis of the C-X-C chemokine interferon-&#x003b3;-inducible protein-10 in experimental canine endotoxemia</article-title><source>Cell Tissue Res</source><year>2000</year><volume>302</volume><fpage>365</fpage><lpage>376</lpage><pub-id pub-id-type="pmid">11151448</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asano</surname><given-names>T</given-names></name><name><surname>Ogawa</surname><given-names>S</given-names></name></person-group><article-title>Expression of monocyte chemoattractant protein-1 in Kawasaki Disease: The Anti-inflammatory effect of gamma globulin therapy</article-title><source>Scand J Immunol</source><year>2000</year><volume>51</volume><fpage>98</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">10632983</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>B</given-names></name><name><surname>Burns</surname><given-names>AR</given-names></name><name><surname>Suematsu</surname><given-names>M</given-names></name><name><surname>Issekutz</surname><given-names>TB</given-names></name><name><surname>Woodman</surname><given-names>RC</given-names></name><name><surname>Kubes</surname><given-names>P</given-names></name></person-group><article-title>Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1</article-title><source>J Clin Invest</source><year>1999</year><volume>103</volume><fpage>1269</fpage><lpage>1276</lpage><pub-id pub-id-type="pmid">10225970</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jibiki</surname><given-names>T</given-names></name><name><surname>Terai</surname><given-names>M</given-names></name><name><surname>Shima</surname><given-names>M</given-names></name><name><surname>Ogawa</surname><given-names>A</given-names></name><name><surname>Hamada</surname><given-names>H</given-names></name><name><surname>Kanazawa</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Oana</surname><given-names>S</given-names></name><name><surname>Kohno</surname><given-names>Y</given-names></name></person-group><article-title>Monocyte chemoattractant protein 1 gene regulatory region polymorphism and serum levels of monocyte chemoattractant protein 1 in Jananese patients with Kawasaki disease</article-title><source>Arthritis Rheum</source><year>2001</year><volume>44</volume><fpage>2211</fpage><lpage>2212</lpage><pub-id pub-id-type="pmid">11592387</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuruta</surname><given-names>J</given-names></name><name><surname>Sugisaki</surname><given-names>K</given-names></name><name><surname>Dannenberg</surname><given-names>AM</given-names><suffix>Jr</suffix></name><name><surname>Yoshimura</surname><given-names>T</given-names></name><name><surname>Abe</surname><given-names>Y</given-names></name><name><surname>Mounts</surname><given-names>P</given-names></name></person-group><article-title>The cytokines NAP-1(IL-8), MCP-1, IL-1&#x003b2; and GRO in rabbit inflammatory skin lesions produced by the chemical irritant sulfur mustard</article-title><source>Inflammation</source><year>1996</year><volume>20</volume><fpage>293</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">8796382</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tettelbach</surname><given-names>W</given-names></name><name><surname>Nanney</surname><given-names>L</given-names></name><name><surname>Ellis</surname><given-names>D</given-names></name><name><surname>King</surname><given-names>L</given-names></name><name><surname>Richmond</surname><given-names>A</given-names></name></person-group><article-title>Localization of MGSA/GRO protein in cutaneous lesions</article-title><source>J Cutan Pathol</source><year>1993</year><volume>20</volume><fpage>259</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">8366215</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koch</surname><given-names>AE</given-names></name><name><surname>Kunkel</surname><given-names>SL</given-names></name><name><surname>Shah</surname><given-names>MR</given-names></name><name><surname>Hosaka</surname><given-names>S</given-names></name><name><surname>Halloran</surname><given-names>MM</given-names></name><name><surname>Haines</surname><given-names>GK</given-names></name><name><surname>Burdick</surname><given-names>MD</given-names></name><name><surname>Pope</surname><given-names>RM</given-names></name><name><surname>Strieter</surname><given-names>RM</given-names></name></person-group><article-title>Growth-related gene product alpha. A chemotactic cytokine for neutrophils in rheumatoid arthritis</article-title><source>J Immunol</source><year>1995</year><volume>155</volume><fpage>3660</fpage><lpage>3666</lpage><pub-id pub-id-type="pmid">7561066</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isaacs</surname><given-names>KL</given-names></name><name><surname>Sartor</surname><given-names>RB</given-names></name><name><surname>Haskill</surname><given-names>S</given-names></name></person-group><article-title>Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification</article-title><source>Gastroenterology</source><year>1992</year><volume>103</volume><fpage>1587</fpage><lpage>1695</lpage><pub-id pub-id-type="pmid">1426879</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strieter</surname><given-names>RM</given-names></name><name><surname>Polverini</surname><given-names>PJ</given-names></name><name><surname>Arenberg</surname><given-names>DA</given-names></name><name><surname>Walz</surname><given-names>A</given-names></name><name><surname>Opdenakker</surname><given-names>G</given-names></name><name><surname>Van Damme</surname><given-names>J</given-names></name><name><surname>Kunkel</surname><given-names>SL</given-names></name></person-group><article-title>Role of C-X-C chemokines as regulators of angiogenesis in lung cancer</article-title><source>J Leukoc Biol</source><year>1995</year><volume>57</volume><fpage>752</fpage><lpage>762</lpage><pub-id pub-id-type="pmid">7539029</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>F</given-names></name><name><surname>Dannenberg</surname><given-names>AM</given-names><suffix>Jr</suffix></name><name><surname>Higuchi</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>Pula</surname><given-names>PJ</given-names></name><name><surname>Hugli</surname><given-names>TE</given-names></name><name><surname>Discipio</surname><given-names>RG</given-names></name><name><surname>Kreutzer</surname><given-names>DL</given-names></name></person-group><article-title>Chemotactic factors released in culture by intact developing and healing skin lesions produced in rabbits by the irritant sulfur mustard</article-title><source>Inflammation</source><year>1997</year><volume>21</volume><fpage>251</fpage><lpage>267</lpage><pub-id pub-id-type="pmid">9187966</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuruta</surname><given-names>J</given-names></name><name><surname>Sugisaki</surname><given-names>K</given-names></name><name><surname>Dannenberg</surname><given-names>AM</given-names><suffix>Jr</suffix></name><name><surname>Yoshimura</surname><given-names>T</given-names></name><name><surname>Abe</surname><given-names>Y</given-names></name><name><surname>Mounts</surname><given-names>P</given-names></name></person-group><article-title>The cytokines NAP-1 (IL-8), MCP-1, IL-1 beta and GRO in rabbit inflammatory skin lesions produced by the chemical irritant sulfur mustard</article-title><source>Inflammation</source><year>1996</year><volume>20</volume><fpage>293</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">8796382</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asano</surname><given-names>T</given-names></name><name><surname>Ogawa</surname><given-names>S</given-names></name></person-group><article-title>Expression of IL-8 in Kawasaki disease</article-title><source>Clin Exp Immunol</source><year>2000</year><volume>122</volume><fpage>514</fpage><lpage>519</lpage><pub-id pub-id-type="pmid">11122263</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>M</given-names></name><name><surname>Silverman</surname><given-names>ED</given-names></name><name><surname>Fish</surname><given-names>EN</given-names></name></person-group><article-title>Evidence for RANTES, monocyte chemotactic protein-1, and macrophage inflammatory protein-1&#x003b2; expression in Kawasaki disease</article-title><source>J Rheumatol</source><year>1997</year><volume>24</volume><fpage>1179</fpage><lpage>1185</lpage><pub-id pub-id-type="pmid">9195529</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Noda</surname><given-names>E</given-names></name><name><surname>Miyawaki</surname><given-names>M</given-names></name><name><surname>Takeuchi</surname><given-names>T</given-names></name><name><surname>Uemura</surname><given-names>S</given-names></name><name><surname>Koike</surname><given-names>M</given-names></name></person-group><article-title>Serum levels of neutrophil activation cytokines in Kawasaki disease</article-title><source>Pediatr Int</source><year>2001</year><volume>43</volume><fpage>115</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">11285059</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>JW</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Lee</surname><given-names>KS</given-names></name></person-group><article-title>Immunologic alterations of peripheral mononuclear cells by intravenous immunoglobulin in the acute stage of Kawasaki disease</article-title><source>J Korean Pediatr Soc</source><year>1998</year><volume>41</volume><fpage>813</fpage><lpage>824</lpage></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>DM</given-names></name><name><surname>Diamond</surname><given-names>LK</given-names></name><name><surname>Howell</surname><given-names>DA</given-names></name></person-group><article-title>Anaphylactoid purpura in children (Henoch-Sch&#x000f6;nlein purpura syndrome)</article-title><source>Am J Dis Child</source><year>1960</year><volume>99</volume><fpage>147</fpage><lpage>168</lpage></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muslu</surname><given-names>A</given-names></name><name><surname>Islek</surname><given-names>I</given-names></name><name><surname>Gok</surname><given-names>F</given-names></name><name><surname>Aliyazicioglu</surname><given-names>Y</given-names></name><name><surname>Dagdemir</surname><given-names>A</given-names></name><name><surname>Dundaroz</surname><given-names>R</given-names></name><name><surname>Kucukoduk</surname><given-names>S</given-names></name><name><surname>Sakarcan</surname><given-names>A</given-names></name></person-group><article-title>Endothelin levels in Henoch-Sch&#x000f6;nlein purpura</article-title><source>Pediatr Nephrol</source><year>2002</year><volume>17</volume><fpage>920</fpage><lpage>925</lpage><pub-id pub-id-type="pmid">12432435</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Besas</surname><given-names>N</given-names></name><name><surname>Saatci</surname><given-names>U</given-names></name><name><surname>Ruacan</surname><given-names>S</given-names></name><name><surname>Ozen</surname><given-names>S</given-names></name><name><surname>Sungur</surname><given-names>A</given-names></name><name><surname>Bakkaloglu</surname><given-names>A</given-names></name><name><surname>Elnahas</surname><given-names>AM</given-names></name></person-group><article-title>The role of cytokines in Henoch-Sch&#x000f6;nlein purpura</article-title><source>Scand J Rheumatol</source><year>1997</year><volume>26</volume><fpage>456</fpage><lpage>460</lpage><pub-id pub-id-type="pmid">9433407</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>TH</given-names></name><name><surname>Wu</surname><given-names>SC</given-names></name><name><surname>Huang</surname><given-names>TP</given-names></name><name><surname>Yu</surname><given-names>CL</given-names></name><name><surname>Tsai</surname><given-names>CY</given-names></name></person-group><article-title>Increased excretion of tumor necrosis factor alpha and interleukin 1&#x003b2; in urine from patients with IgA nephropathy and schonlein-Hen&#x000f6;ch purpura</article-title><source>Nephron</source><year>1996</year><volume>74</volume><fpage>79</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">8883024</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Besbas</surname><given-names>N</given-names></name><name><surname>Saatci</surname><given-names>U</given-names></name><name><surname>Ruacan</surname><given-names>S</given-names></name><name><surname>Ozen</surname><given-names>S</given-names></name><name><surname>Sungur</surname><given-names>A</given-names></name><name><surname>Bakkaloglu</surname><given-names>A</given-names></name><name><surname>Elnahas</surname><given-names>AM</given-names></name></person-group><article-title>The role of cytokines in Henoch Sch&#x000f6;nlein purpura</article-title><source>Scand J Rheumatol</source><year>1997</year><volume>26</volume><fpage>456</fpage><lpage>460</lpage><pub-id pub-id-type="pmid">9433407</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redhead</surname><given-names>K</given-names></name><name><surname>Watkins</surname><given-names>J</given-names></name><name><surname>Barnard</surname><given-names>A</given-names></name><name><surname>Mills</surname><given-names>KH</given-names></name></person-group><article-title>Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity</article-title><source>Infect Immun</source><year>1993</year><volume>61</volume><fpage>3190</fpage><lpage>3198</lpage><pub-id pub-id-type="pmid">8335349</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bucklin</surname><given-names>SE</given-names></name><name><surname>Silverstein</surname><given-names>R</given-names></name><name><surname>Morrison</surname><given-names>DC</given-names></name></person-group><article-title>An Interleukin-6-Induced acute-phase response does not confer protection against lipopolysaccharide lethality</article-title><source>Infect Immun</source><year>1993</year><volume>61</volume><fpage>3184</fpage><lpage>3189</lpage><pub-id pub-id-type="pmid">8335348</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname><given-names>HS</given-names></name><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Lee</surname><given-names>YS</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name></person-group><article-title>Effect of C. albicans on IL-6 gene expression of human peripheral blood lymphocytes</article-title><source>Korean J Immunol</source><year>1997</year><volume>19</volume><fpage>263</fpage><lpage>275</lpage></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valbuena</surname><given-names>G</given-names></name><name><surname>Bradford</surname><given-names>W</given-names></name><name><surname>Walker</surname><given-names>DH</given-names></name></person-group><article-title>Expression analysis of the T-cell-targeting chemokines CXCL9 and CXCL10 in mice and humans with endothelial infections caused by rickettsiae of the spotted fever group</article-title><source>Am J Pathol</source><year>2003</year><volume>163</volume><fpage>1357</fpage><lpage>1369</lpage><pub-id pub-id-type="pmid">14507644</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Fig. 1</label><caption><p>The chemokine IP-10 levels in plasma. KD, Kawasaki disease; HSP, Henoch-Sch&#x000f6;nlein purpura; AFI, Acute febrile illnesses.</p></caption><graphic xlink:href="jkms-19-800-g001"/></fig><fig id="F2" position="float"><label>Fig. 2</label><caption><p>The chemokine MCP-1 levels in plasma. KD, Kawasaki disease; HSP, Henoch-Sch&#x000f6;nlein purpura; AFI, Acute febrile illnesses.</p></caption><graphic xlink:href="jkms-19-800-g002"/></fig><fig id="F3" position="float"><label>Fig. 3</label><caption><p>The chemokine Gro-&#x003b1; levels in plasma. KD, Kawasaki disease; HSP, Henoch-Sch&#x000f6;nlein purpura; AFI, Acute febrile illnesses.</p></caption><graphic xlink:href="jkms-19-800-g003"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>The characteristics of study group</p></caption><graphic xlink:href="jkms-19-800-i001"/><table-wrap-foot><fn><p>KD, Kawasaki disease; HSP, Henoch-Sch&#x000f6;nlein purpura; AFI, Acute febrile illnesses.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>The plasma level of chemokines (pg/mL)</p></caption><graphic xlink:href="jkms-19-800-i002"/><table-wrap-foot><fn><p>KD, Kawasaki disease; HSP, Henoch-Sch&#x000f6;nlein purpura; AFI, Acute febrile illnesse.</p></fn></table-wrap-foot></table-wrap></floats-group></article>
